N/A
N=1,490
Blood Tests for Gastritis and Gastric Neoplasms
Cancer Screening Tests
Bottom Line
View on ClinicalTrials.gov: NCT05883345 ↗Enrolled (actual)
1,490
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Significant Blood Test Findings Correlated With Gastric Neoplasms — 9.9; 6.5 score on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Serum blood test for Helicobacter pylori immunoglobulin G, pepsinogen, and gastrin-17 levels (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Konkuk University Medical Center
- Primary completion
- Aug 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Significant Blood Test Findings Correlated With Gastric Neoplasms |
9.9; 6.5 | — |
| SECONDARY Test Findings Correlated With the Presence of Gastric Neoplasms |
2.9; 11.8 | — |
Summary
Helicobacter pylori infection rate is decreasing in younger population; however, biennial gastroscopy is still recommended for all Koreans aged between 40 and 75 years. This study aimed to validate blood tests for gastric cancer screening according to the infection status of H. pylori (naive, current, and past infection).
Eligibility Criteria
Inclusion Criteria
- Individuals who visited for gastric cancer screening
Exclusion Criteria
- History of gastrectomy
- Renal insufficiency
- Severe comorbidities requiring prompt management
Data sourced from ClinicalTrials.gov (NCT05883345). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.